WallStreetZenWallStreetZen

NASDAQ: DNLI
Denali Therapeutics Inc Stock Ownership - Who owns Denali Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Denali Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vicki L. SatoDirector2023-09-1540$24.35
$974.00Sell
Vicki L. SatoDirector2023-09-151,626$23.60
$38.37kSell
Carole HoChief Medical Officer2023-08-232,522$23.22
$58.56kSell
Alexander O. SchuthCOFO and Secretary2023-08-232,522$23.17
$58.43kSell
Steve E. KrognesDirector2023-08-211,419$22.60
$32.07kSell
Alexander O. SchuthCOFO and Secretary2023-08-212,478$22.59
$55.98kSell
Ryan J. WattsPresident and CEO2023-08-212,309$22.59
$52.16kSell
Carole HoChief Medical Officer2023-08-212,478$22.60
$56.00kSell
Vicki L. SatoDirector2023-08-151,666$24.30
$40.48kSell
Carole HoChief Medical Officer2023-08-142,768$23.79
$65.85kSell

1 of 7

DNLI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNLI insiders and whales buy or sell their stock.

DNLI Shareholders

What type of owners hold Denali Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen15.10%20,749,930$434.92MInsider
Baillie Gifford Co10.80%14,843,770$311.13MInstitution
Biogen Inc9.69%13,310,243$278.98MInsider
Arch Venture Fund Viii LP7.76%10,668,749$223.62MInsider
Vanguard Group Inc7.45%10,242,983$214.69MInstitution
Blackrock Inc7.35%10,106,275$211.83MInstitution
Douglas K. Bratton7.34%10,084,938$211.38MInsider
Fmr LLC7.12%9,779,988$204.99MInsider
Flagship Ventures Fund V LP6.49%8,918,749$186.94MInsider
Wellington Management Group LLP5.12%7,038,176$147.52MInstitution

1 of 3

DNLI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNLI55.73%44.27%Net SellingNet Selling
CYTK87.80%12.20%Net SellingNet Selling
AKRO66.26%33.74%Net SellingNet Buying
NTLA67.03%32.97%Net SellingNet Selling
CORT29.64%70.36%Net BuyingNet Selling
View Top Biotech Stocks

Denali Therapeutics Stock Ownership FAQ

Who owns Denali Therapeutics?

Denali Therapeutics (NASDAQ: DNLI) is owned by 78.03% institutional shareholders, 61.98% Denali Therapeutics insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Denali Therapeutics shareholder, owning 20.75M shares representing 15.10% of the company. Robert Nelsen's Denali Therapeutics shares are currently valued at $428.07M.

If you're new to stock investing, here's how to buy Denali Therapeutics stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.